Cord Blood Therapies
CLEVECORD (HPC Kordon Kanı)
CLEVELAND CORD BLOOD CENTER
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC Kordon Kanı
BLOODWORKS
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC Kordon Kanı
MD ANDERSON CORD BLOOD BANK
Approved by the U.S. FDA in June 2018 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
Hemacord (HPC Kordon Kanı)
NEW YORK BLOOD CENTER
Approved by the U.S. FDA in 2011 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
Allocord (HPC Kordon Kanı)
SSM CARDINAL GLENNON CHILDREN’S MEDICAL CENTER
Approved by the U.S. FDA in 2013 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
Ducord (HPC Kordon Kanı)
DUKE UNIVERSITY MEDICAL CENTER
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC Kordon Kanı
CLINIMMUNE
Approved by the U.S. FDA in 2012 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
HPC Kordon Kanı
LIFE SOUTH
Approved by the U.S. FDA in 2016 for use in unrelated donor hematopoietic progenitor cell transplantation procedures.
